PRESS RELEASE
News
-
-
PRESS RELEASE
DEAG acquires HOW TO ACADEMY and strengthens dynamically growing Spoken Word & Literary Events segment
DEAG Deutsche Entertainment Aktiengesellschaft has acquired 85% of the British company How To Academy, further strengthening its position in the Spoken Word & Literary Events segment. The acquisition is expected to bring significant synergy effects and cross-selling potential, particularly in the area of digital events. DEAG continues to grow dynamically in this segment and is well-positioned for international expansion. -
PRESS RELEASE
Original-Research: DEMIRE AG (von NuWays AG): HOLD
This press release provides an update on DEMIRE AG's annual portfolio revaluation, noting a decline in the fair value of investment properties by 12-14%. The analysis predicts further devaluation in FY '24e but expects the company's operations and FY guidance to remain unaffected. The focus is on refinancing the corporate bond set to mature in October, and the recommendation stands at HOLD with an unchanged PT of € 1.20 based on NAV and DDM. -
PRESS RELEASE
Original-Research: Westwing Group AG (von NuWays AG): BUY
This press release provides an original research report by NuWays AG, now reclassifying Westwing Group AG. The report presents Westwing as a storytelling-based value and growth play for 2024, with a focus on its unique retail approach and inspiration-driven revenue generation in the home and living segment. It highlights the company's strong gross margins, sales growth projections, and strategic efforts to improve customer experience and product offering. Moreover, it emphasizes Westwing's healthy balance sheet, generating potential for investors to benefit from an eventual market recovery. The press release also includes contact information for further inquiries and access to the full analysis. -
PRESS RELEASE
Transaction in Own Shares
Nordea Bank Abp has announced the completion of the repurchase of its own shares in public trading, in line with the share buy-back programme authorized by Nordea's Annual General Meeting 2023. The transactions were executed in accordance with the relevant regulations, resulting in Nordea holding a specified number of treasury shares for capital optimization and remuneration purposes. -
REGULATED PRESS RELEASE
Cie du Bois Sauvage : Rachat d’actions propres – semaine du 15/01/2024 au 19/01/2024
La Compagnie du Bois Sauvage déclare avoir procédé au rachat d'actions propres sur le marché réglementé NYSE Euronext Bruxelles conformément à l'autorisation de l'assemblée générale extraordinaire du 28 avril 2021 -
REGULATED PRESS RELEASE
Cie du Bois Sauvage: Buy back of own shares – week from 15/01/2024 to 19/01/2024
Cie du Bois Sauvage announces the buyback of own shares on the regulated NYSE Euronext Market Brussels from 15/01/2024 to 19/01/2024, in accordance with the authorization of the extraordinary general meeting of April 28, 2021. The total number of shares bought back since October 2, 2023 amounted to 6 454 (0,4 % of the total number of shares) for a total amount of € 1 773 643,00. -
-
PRESS RELEASE
Velox Drilling Identifies High-grade Vanadium Zone within the Cambridge Deposit in Queensland, Australia
Velox Energy Materials Inc. (TSXV:VLX) is pleased to announce the successful results of its Phase 1 diamond drill program at the Cambridge Vanadium deposit in North Queensland Vanadium Project. The drilling results have revealed encouraging assay results, with a mineralized zone identified at shallow depths, uniform thicknesses, and consistent grades. This has enhanced the overall understanding of the deposit, with the potential for new parameters to be applied across the entire project area. The company is now planning to conduct metallurgical studies and update the existing resource based on the promising findings. -
PRESS RELEASE
Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals
Eckert & Ziegler (ISIN DE0005659700, SDAX) and Full-Life Technologies have signed an agreement for the supply of Actinium-225 (Ac-225), a radionuclide for developing the next generation of therapeutic radiopharmaceuticals. The agreement aims to increase access to Ac-225, which is vital for advancing the development and clinical research efforts of Full-Life Technologies.
